According to Alzamend Neuro latest financial reports the cash on hand of ALZN is $5.14M, an decrease of -63.45% to 2022. At the end of 2022 company had $14.06M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $5.14M | -63.45% |
2022 | $14.06M | 628.97% |
2021 | $1.93M | 2036.87% |
2020 | $90.28K | 111.91% |
2019 | $42.61K | - |